Hood River Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-322,398
Closed -$15.5M 129
2019
Q2
$15.5M Sell
322,398
-632,508
-66% -$33.2M 0.73% 60
2019
Q1
$59.8M Sell
954,906
-36,215
-4% -$2.49M 3.01% 1
2018
Q4
$59.2M Sell
991,121
-144,438
-13% -$8.67M 3.49% 2
2018
Q3
$73.2M Buy
1,135,559
+25,773
+2% +$1.44M 3.24% 1
2018
Q2
$49.9M Sell
1,109,786
-95,725
-8% -$3.82M 2.56% 3
2018
Q1
$37.4M Buy
1,205,511
+14,885
+1% +$489K 2.1% 10
2017
Q4
$35.6M Buy
1,190,626
+282,687
+31% +$8.19M 2.06% 11
2017
Q3
$30M Buy
907,939
+109,921
+14% +$3.81M 1.9% 11
2017
Q2
$26.7M Buy
+798,018
New +$23.8M 1.84% 12

Other funds holding BEAT

Hood River Capital Management's BEAT Position: Q3 2019 in Review

Hood River Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 322,398 shares — an estimated $15.5M sold.

Hood River Capital Management first reported a position in BEAT in Q2 2017 and held it in 9 quarters. The position peaked at $73.2M in Q3 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Hood River Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • Hood River Capital Management sold 322,398 BioTelemetry, Inc. shares in Q3 2019, an estimated $15.5M.
  • Hood River Capital Management first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 9 quarters.
  • Hood River Capital Management's BioTelemetry, Inc. position peaked at $73.2M in Q3 2018.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Hood River Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.